Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:56 AM
Ignite Modification Date:
2025-12-26 @ 3:56 AM
NCT ID:
NCT03049618
Group ID:
EG001
Title:
Non-Small Cell Lung Cancer Cohort
Description:
Patients receive pembrolizumab IV over 30 minutes on day 1 and recombinant EphB4-HSA fusion protein IV over 30 minutes on days 1, 8, and 15. Courses repeat every 3 weeks for up to 24 months in the absence of disease progression or unacceptable toxicity.
Laboratory Biomarker Analysis: Correlative studies
Pembrolizumab: Given IV
Recombinant EphB4-HSA Fusion Protein: Given IV
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
17
Other Number Affected:
11
Other Number At Risk:
17
Study:
NCT03049618
Results Section:
NCT03049618
Adverse Events Module:
NCT03049618